Delivery Order SPE2DB20D3103-SPE2DB25FQ0R8
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,194.60 to AmerisourceBergen Drug Corp for Desmopressin 40 mcg/10 mL vials on August 28, 2025, with an ultimate completion date of August 29, 2025. This competitive award, issued under a firm fixed price contract type with no set-aside designation, is being fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a single delivery order for pharmaceutical products...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the provision of 4,568,798,606 units of the medication desmopressin 40 mcg/10 ml vial 10 ml. The contract has a ceiling value of $1,793.26 and a completion date of July 16, 2025. It is not a set-aside contract, indicating open competition. Amerisourcebergen Drug Corp is the prime contractor and holds a significant Indefinite...
- The Defense Logistics Agency awarded a $24,160 delivery order to AmerisourceBergen Drug Corporation for desmopressin acetate 0.01% solution. The order was placed under an indefinite-delivery/indefinite-quantity contract vehicle to supply pharmaceutical products and services to DOD and other federal agencies. AmerisourceBergen will deliver the desmopressin solution from its facility in Conshohocken, Pennsylvania on a firm fixed price basis, with performance required from July 13-14, 2023. No...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of pharmaceutical products. The award has a ceiling value of $3,136.00 and an ultimate completion date of September 30, 2024. The contract is for the delivery of desmopressin, a medication used to treat certain hormone deficiencies, with the specific item being 4565965426 - DESMOPRESSIN 40 MCG/10 ML VIAL 10ML. The contract is a firm fixed-price arrangement, with no...
- This federal contract award is for the delivery of Desmopressin 40 mcg/10 mL vial 10 mL to the Defense Logistics Agency (DLA). The $3,484.72 firm fixed-price delivery order was awarded on May 12, 2022 to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract has a period of performance through May 13, 2022. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that has established itself as a key vendor for federal healthcare...
- This contract award, with a ceiling value of $1,056.30, was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The award is for the delivery of desmopressin 40 mcg/10 ml vials, with a completion date of December 1, 2023. The contract is a delivery order, with a firm fixed price pricing type. This award is not associated with a set-aside program. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that serves as a key vendor...
- The Defense Logistics Agency awarded a delivery order valued at $1,373.56 to AmerisourceBergen Drug Corp for Vasopressin 20 Unit/ML vials. This competitively awarded, firm fixed-price delivery order was finalized on August 20, 2025, with an ultimate completion date of August 21, 2025. The pharmaceutical product will be delivered to the Place of Performance in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters. This award represents a child contract...
- <p>This firm fixed price delivery order for one hundred six dollars was awarded by the Defense Logistics Agency Troop Support Medical to Amerisourcebergen Drug Corporation for the product DESMOPRESSIN 5ML 1S. The place of performance is Conshohocken, Pennsylvania and the period of performance concludes on October 18, 2023. No set-aside designation was used for this award.</p>
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of DDAVP 40 MCG/10 ML VIAL 10ML, a pharmaceutical product. The contract has a ceiling value of $1,497.74 and a period of performance through May 14, 2024. The contract is a firm fixed price type and does not have a set-aside designation. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which is doing business as AmerisourceBergen. This...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a firm fixed-price delivery order valued at $17,524.44 to AmerisourceBergen Drug Corp on July 27, 2025, with an ultimate completion date of July 28, 2025. This non-set-aside contract was competitively awarded and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The delivery order...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB25FQ0R8Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,177.70 to AmerisourceBergen Drug Corp for Desmopressin 40 MCG/10 ML vials on August 28, 2025, with completion expected by August 29, 2025. This non-set-aside contract utilizes firm fixed pricing and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, demonstrates significant capability in fulfilling federal medical procurement requirements through its extensive portfolio of pharmaceutical products and medical supplies. As a prime vendor for DLA's medical supply chain, the company supplies a comprehensive range of medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains to support Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. This delivery order for Desmopressin—a medication used in treating diabetes insipidus and certain bleeding disorders—exemplifies the company's ongoing role in providing critical pharmaceutical commodities to support military and veteran healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 8/28/25 |